GlaxoSmithKline wants to sell more than a third of the space at its R&D campus in Stevenage, UK, to a new bioscience cluster that it says could become one of the largest in Europe.

GlaxoSmithKline has hired computational drug design specialist Dr Kim Branson to expand its artificial intelligence and machine learning unit. Branson joins the pharma group as senior vice ...

Located in Ware, Riverlabs sits on the Cambridge to Kings Cross life sciences Innovation Corridor within a 45-minute radius of London, Cambridge and the established Cell and Gene Therapy Catapult in ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

Kieran Dowell arrived on loan at Birmingham from Rangers in January Birmingham moved 14 points clear at the top of League One after beating spirited Stevenage at St Andrew's @ Knighthead Park.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the ...